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Obesity, the excessive accumulation of body fat, is amain defining feature of the metabolic syndrome,
and overweight is often an early indication of the future
severity and development of associated pathologies. There
is a graded relationship between the increase in body ad-
ipose tissue content and the severity of insulin resistance,
hypertension, and altered blood lipids, in addition to a
number of additional disturbances in energy, nitrogen,
and xenobiotic metabolism.
It is widely accepted that the manifestation of the met-
abolic syndrome cluster of diseases stems from the con-
tinued exposure to environmental factors [mainly diet,
and especially fat intake (1)] modulated by genetic factors
and epigenetic upbringing (2). Abundance of triacylglyc-
erols in the diet translates into excess fatty acid availabil-
ity, which in turn limits the utilization of dietary glucose
by muscle and other tissues; we are adapted to first dispose
of fatty acids for energy, preserving the glucose for the
brain, as in starvation mode. Insulin resistance is, there-
fore a direct consequence of these preestablished priorities
in the use of substrates under conditions of abundance of
both carbohydrate and lipid.
Nonetheless, the primarily unused but readily available
energy must be processed and/or disposed of somehow.
This is accomplished by a number of partial solutions,
including increased energy expenditure (thermogenesis,
substrate cycling, and faster protein turnover), but the
most immediate (and thrifty) solution is to store the excess
energy as fat for eventual use under conditions of scarcity.
This storage is widely distributed, including the liver, mus-
cle, and other organs, but their overall cumulative capacity
is limited. In contrast, adipose tissue’s main function is
precisely such caloric storage. Consequently, the adipo-
cyte ends up with most of the surplus energy, largely be-
cause its barriers to prevent the accumulation of excess
circulating glucose are not as effective as those that have
been identified in muscle. The adipocyte incorporates fatty
acids from lipoproteins and also takes a significant portion
of the excess circulating glucose, which is used for lipo-
genesis and/or lactate production. Adipose tissue accumu-
lation of excess triacylglycerols induces adipocyte hyper-
trophia, as well as relative hypoxia (in part due to tissue
enlargement) (3) and acidosis because of glucose conver-
sion to lactate (4).
The storage of surplus lipids in adipose tissue, how-
ever, cannot be sustained indefinitely— the tissue can-
not grow to an impossible size, destabilizing the phys-
iological systems and potentially placing survival at
serious risk. One might consider massive obesity as pro-
pelling the body toward the verge of systemic physio-
logical collapse. Because it is difficult to process a con-
stant energy input surplus indefinitely, adipose tissue
appears to react to such excess energy dumping as if it
were an aggression to its integrity and function. This
reaction is mainly carried out by at least three mecha-
nisms: 1) decreasing cell metabolism, especially the en-
try of substrates, glucose utilization and lipogenesis, to
limit the incorporation of more energy; 2) secreting of
cytokine and other metabolic signals to correct hyp-
oxia, reducing the excessive size of fat depots (including
apoptosis), and dampening tissue reactivity to hormone
signals (e.g. insulin) that facilitate fat deposition; and 3)
increasing diapedesis to favor the massive infiltration of
immune cells to fight the aggression through depression
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of cellular metabolism, the alteration of hormone sig-
naling, the blockage of access to substrates, their uptake
and accumulation, and inducing apoptosis and the ar-
rest of cell differentiation and growth.
The well-known infiltration of macrophages (and their
transformation) and of other cells of the immune system
helps stem the growth of adipose tissue reserves but si-
multaneously results in the loss of the adipose tissue func-
tion as flexible energy storage buffer and depot. The whole
set of defense reactions is akin to inflammation and ex-
tends its influence to surrounding organs (e.g. blood ves-
sels, muscle) and to the body as a whole, helping to pro-
mote a systemic derangement—namely, the metabolic
syndrome (5). Paradoxically, the initial objective of this
response was to stop the pathological consequences of an
indefinite accumulation of fat.
This is a situation in which the excess of energy in the
form of dietary fats, but also of all other nutrients, over-
comes our ability for energy storage, which was set for
conditions that have evolved to protect us from starvation.
In contrast, facing an excess of energy is a complete nov-
elty from the point of view of the evolutionary struggle for
survival. The logical reaction to this new challenge is the
“preset” mobilization of defense systems. The result is to
fight a problem of metabolic disarrangement with inade-
quate means, which were primarily designed to confront
alien organisms and their proteins, not the energy sub-
strates always sought for.
In the paper by Klimcˇa´kova´ et al. (6), published in this
issue of JCEM, the careful analysis of the expression of
omental and sc adipose tissue of humans reveals a remark-
able convergence in the mechanisms of adaptation to the
metabolic syndrome for both fat depots. In the two sites,
there was a macroscopic advance of the disease along a
series of human groups with varying degrees of adiposity
(lean, overweight, obese, and obese with overt metabolic
syndrome). These different grades of body fat were par-
alleled by an increase in the expression of genes related to
immune defense and a fall in those linked to overall me-
tabolism, including cell energy maintenance processes.
Significantly, the pattern was the same for both adipose
tissue locations despite small differences attributable to
their developmental origin and physiological function.
The accumulation of excess fat in adipose tissue makes
it not only dysfunctional but a potential hindrance to mo-
bility and a source of metabolic misadjustment, irrespec-
tive of its location and the initial (i.e. normal) specific
function of the site. The limitation of the extent of damage
by preventing indefinite adipose tissue accumulation is
coincident with the infiltration of immune system cells
in adipose tissue. These cells are directly (or indirectly
through their influence on adipocytes and stromal cells)
responsible for the “cytokine storm” that extends to and
beyond the adipose tissue masses and condition the de-
velopment of the metabolic syndrome.
The sex-related differences in fat distribution correlate
with a fairly different degree of severity of the metabolic
consequences associated with excess fat accumulation.
The android (or upper body) pattern, with a high predom-
inance of visceral vs. sc fat, induces more intense delete-
rious change than the gynoid (or lower body) pattern. This
has brought in the consequential idea that the presence of
fat depots in different sites results in markedly disparate
metabolic consequences. Most studies on adipose tissue
changes and development of its alterations related to hy-
pertrophia have been performed in rodents, and the dis-
tinct functions of their adipose tissue sites have been iden-
tified and characterized. However, there is not a direct
correspondence between location and function in humans
and rodents (e.g. the massive perigonadal fat pads of rats
and mice and the practical quantitative irrelevance of these
fat depots in humans). Most of the fat tissue present in the
visceral cavity of obese rodents is not drained via the portal
vein, in marked contrast to humans in which truly visceral
adipose tissue is largely omental, closely related to the
intestine. The differences between human and rodent ad-
ipose tissue distribution (and function) is an important
caveat to the widespread assumptions that all adipose tis-
sue sites placed inside the visceral space are equal and,
consequently, functionally interchangeable.
The Klimcˇa´kova´ et al. (6) study confirms previous find-
ings that uncomplicated obesity alone (i.e. the simple ac-
cumulation of fat) is not pathologically serious enough (7)
to trigger a full response of the immune system. Then,
what is the primary cause for the defensive reaction of
adipose tissue to such excess energy aggression? And why
is there a change in the expression of adipose tissue cells’
metabolism toward a “minimum maintenance” status of
cells already hypertrophied? In fact, and despite massive
enlargement, adipose tissue cell sizes are different in dif-
ferent sites (8), and their actual metabolic response to hor-
monal stimuli is also distinct; however, all of them main-
tain the ability to carry on lipolysis and to metabolize
glucose, largely to lactate.
Despite considerable work done on the mechanisms
triggering (and maintaining) the inflammatory response in
adipose tissue, we still don’t know the precise sequence
(and timing) of events for the development of this adipose
tissue “malaise,” which results in a partial loss of function
as a consequence of its interaction with the immune cells.
We can understand the infiltration as a response to distress
signals (e.g. TNF) from overstretched or hypoxic adipo-
cytes. Their hypometabolic state may be a way to minimize
their implication in energy metabolism that helps them
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reject circulating substrates. However, this does not ex-
plain why all such processes do not also occur in “uncom-
plicated” obesity: the excess energy is present; the stimuli
from damaged, overstretched, and hypoxic cells may be
the same; but immune cell infiltration and its conse-
quences are not observed. This may obviously be related
in part to the development of the metabolic syndrome over
time, which usually takes a significant number of years of
nutritional aggression to become manifest.
The increased activation of glucocorticoids by adipose
tissue, due in part to an increased expression (and activity)
of 11-hydroxysteroid dehydrogenase type 1 (9), may be
in itself a sign of defense of the tissue against the excesses
of the inflammatory response. This may be both a con-
sequence of counterregulatory mechanisms to limit the
extent of the immune system-driven reaction and an
effect of the cytokine secretion defensive barrier altering
the overall hormonal regulation of energy partition.
However, this assumption does not explain why the
simple sum of all these factors requires the additional
passage of an inordinate amount of time to fully develop
the metabolic syndrome.
In conclusion, the loss of adipose tissue function, its
“occupation”by immunecells, and the ensuingalterations
of cell apoptosis and oxygen supply (hypoxia, angiogen-
esis, blood flow control) seem a logical consequence of
excessive fat accumulation. Often, however, obesity pre-
cedes the setting of a full-fledged metabolic syndrome, as
shown by the Klimcˇa´kova´ et al. (6) study. It may seem that
the response of adipose tissue (including the immune cell
hosts) to the aggressive storage of energy is in itself a crit-
ical factor in the pathogenesis of the metabolic syndrome,
but additional factors are needed to allow the full negative
consequences of the metabolic syndrome to develop. The
unveiling of these factors, probably endocrine, related to
time (age) may help us to better understand the metabolic
syndrome and set a solid basis for its treatment.
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